Glenmark Pharma; Visibility improves but concerns prevail, Maintain Hold; Target: Rs 308

lenmark Pharma

Reco: HOLD  

CMP: Rs287

Target Price: Rs308

Visibility improves but concerns prevail, Maintain Hold

·                    Increasing approvals for niche filings and sustainable FTF pipeline with 10-12 ANDA launches annually, improve US market revenue visibility

·                    Domestic market to sustain growth momentum and outperform industry by 200bps

·                    Higher securitized receivables, huge intangibles and R&D capitalization remain key concerns 

·                    Maintain earning estimates with a Hold rating

--
Safe Harbor:
The information contained and provided on this Website provides Investment advice for the education of investors. The posts are an information service only. Recommendations, opinions or suggestions are given with the understanding that readers acting on this information assume all risks involved. We do not assume any responsibility or liability resulting from the use of such information, judgment and opinions for Trading or Investment purposes.
 
You received this message because you are subscribed to the Google Groups "Investors Please Listen !" group.
To post to this group, send email to investorspleaselisten@googlegroups.com
To unsubscribe from this group, send email to
investorspleaselisten+unsubscribe@googlegroups.com For more options, visit this group at http://groups.google.com/group/investorspleaselisten?hl=en